D Jeffrey Keyser Net Worth & Insider Trades
D Jeffrey Keyser - Director, Lantern Pharma Inc
What is D Jeffrey Keyser's Net Worth?
The current estimated net worth of Lantern Pharma Inc's Director, D Jeffrey Keyser, is estimated to be about $2.52M . D Jeffrey Keyser owns about 10,000 units of Lantern Pharma Inc common stock. In the last year at Lantern Pharma Inc, D Jeffrey Keyser has sold an estimated value of $0 worth.
What is D Jeffrey Keyser's Past Insider Trading?
D Jeffrey Keyser's largest purchase order was 10,000 units , worth over $150K on June 15, 2020. In total, D Jeffrey Keyser has made about 3 transactions over a year of their time at Lantern Pharma Inc. D Jeffrey Keyser usually trades in June, with the busiest year in 2020.
d Jeffrey Keyser
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What was D Jeffrey Keyser's Salary in 2020?
As Director of Lantern Pharma Inc, D Jeffrey Keyser has a total base salary of $82,385 . D Jeffrey Keyser received compensation valued at about $667,608 in 2020 after becoming Director. The vast majority of their compensation came in the form of a bonus of $10,501 , and option awards of $574,722 .
What is D Jeffrey Keyser's' Mailing Address?
- Mailing address is 4848 Loop Central Drive Suite 700 Houston TX 77081 TX
Lantern Pharma Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Total
|
---|---|---|---|---|---|
Panna Sharma, | 2020 | $384,492 | $366,000 | $843,674 | $1,594,166 |
Panna Sharma, | 2019 | $266,923 | $65,000 | - | $331,923 |
David R. Margrave, | 2020 | $225,154 | $73,725 | $862,083 | $1,160,962 |
David R. Margrave, | 2019 | $97,019 | - | - | $97,019 |
Kishor Bhatia, Ph.D., | 2020 | $82,385 | $10,501 | $574,722 | $667,608 |
Kishor Bhatia, Ph.D., | 2019 | $36,873 | - | - | $36,873 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1763950/000121390021020952/def14a0421_lantern.htm
What are Lantern Pharma Inc's Past Insider Trades?
Lantern Pharma Inc's most recent insider trade came on November 9, 2022 by Leslie Kreis, Cavu Management Lp, Cavu Advisors Llc and BP Directors Lp who sold 350,000 units worth $1.54M . In the last 2 years, insiders at Lantern Pharma Inc have sold an estimated value of $3.15M and bought an estimated value of $516.82K worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Bios Advisors GP Llc, Bios Capital Management Lp, and Bios Equity Partners Lp .
Lantern Pharma Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |